Table 4: Factors perceived by Physician and pharmacists to have influenced their choice of antibiotics for patients in Grenada, 2015.

Physicians %, 95% CI, (n) Pharmacists %, 95% CI, (n)
Frequent Occasional Never Frequent Occasionally Never
Cost to the patient 67.6; 49.4-82.0 (23) 17.6; 7.4-35.2 (6) 0.0; 0.0-0.0 83.3; 50.9-97.1 (10) 16.7; 2.9-44.8 (2) 0.0; 0.0-0.0
Severity of infection 85.3; 68.2-94.5 (29) 0.0; 0.0-0.0 0.0; 0.0-0.0 75.0; 42.3-93.3 (9) 25.0; 6.7-57.2 (3) 0.0; 0.0-0.0
The infecting organism (suspected or confirmed) 79.4; 61.6-90.1 (27) 79.4; 61.6-90.1 (27) 5.9; 1.0-21.1 (2) 0.0; 0.0-0.0 63.4; 31.6-87.6 (7) 27.3; 7.3-60.7 (3) 9.1; 0.5-42.3 (1)
Cost to the hospital 41.2; 25.1-59.2 (14) 26.5; 13.5-44.7 (9) 17.6; 7.4-35.2 (6) 41.7; 16.5-71.4 (5) 41.7; 16.5-71.4 (5) 16.7; 2.9-44.8 (2)
Effectiveness of antibiotics for patients typically seen 82.4; 64.8-92.6 (28) 2.9; 0.2-17.1 (1) 0.0; 0.0-0.0 58.3; 28.6-83.5 (7) 41.7; 16.5-71.4 (5) 0.0; 0.0-0.0
Results from samples sent to the laboratory 52.9; 35.4-69.8 (18) 29.4; 15.7-47.7 (10) 2.9; 0.2-17.1 (1) 66.7; 35.4-88.7 (8) 33.3; 11.3-64.6 (4) 0.0; 0.0-0.0
Patients demands and expectations 38.2; 22.7-56.4 (13) 44.1; 27.6-61.9 (15) 2.9; 0.2-17.1 (1) 41.7; 16.5-71.4 (5) 50.0; 22.3-77.7 (6) 8.3; 0.4-40.2 (1)
Profit for the clinician 8.8; 2.3-24.8 (3) 35.3; 20.3-53.5 (12) 41.2 (14) 30.0; 8.1-64.6 (3) 40.0; 13.7-72.6 (4) 30.0; 8.1-64.6 (3)
Hospital or Ministry of Health guidelines 23.5; 11.4-41.6 (8) 47.1; 30.2-64.6 (16) 11.8; 3.8-28.4 (4) 33.3; 11.3-64.6 (4) 58.4; 28.6-83.5 (7) 8.3; 0.4-40.2 (1)
Antibiotic stock available 61.8; 43.6-77.3 (21) 17.6; 7.4-35.2 (6) 5.9; 1.0-21.1 (2) 33.3; 11.3-64.6 (4) 58.4; 28.6-83.5 (7) 8.3; 0.4-40.2 (1)
Influence of pharmaceutical sales representatives 8.8; 2.3-24.8 (3) 55.9; 38.1-72.4 (19) 58.4; 28.6-83.5 (7) 41.7; 16.5-71.4 (5) 41.7; 16.5-71.4 (5) 0.0; 0.0-0.0
Advice from colleagues and/or consultants 44.1; 27.6-61.9 (15) 35.3; 20.3-53.5 (12) 2.9; 0.2-17.1 (1) 27.3; 6.7-57.2 (3) 72.3; 39.3-92.7 (8) 0.0; 0.0-0.0